New eye drop enters final testing to control leading cause of blindness
NCT ID NCT07335211
Summary
This study is testing a new eye drop called HUC3-637 for people with a common type of glaucoma or high eye pressure. It aims to see if it works as well as or better than an existing standard treatment at lowering pressure inside the eye. The trial will involve 206 adults and is in its final phase of testing before potential approval.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OCULAR HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Kangbuk Samsung Hospital
RECRUITINGSeoul, South Korea
Conditions
Explore the condition pages connected to this study.